Variant position: 131 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 363 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human MSHPPPAAREDKSPSEESAP TTSPESVSGSVPSSGSSGREE
Mouse MSHPPPTSREDKSPSEESTT TTSPESISGSVPSSGSSGREE
Bovine MSHPPPTAREDKSPSEESAP TTSPESVSGSVPSSGSGGREE
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
1 – 363 UV excision repair protein RAD23 homolog A
123 – 123 Phosphoserine
128 – 128 Phosphoserine
133 – 133 Phosphoserine
136 – 136 Phosphoserine
138 – 138 Phosphoserine
122 – 122 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)
NIEHS SNPs program;
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]; VARIANTS ALA-131 AND MET-200;
Homo sapiens protein coding cDNA.
Totoki Y.; Toyoda A.; Takeda T.; Sakaki Y.; Tanaka A.; Yokoyama S.; Ohara O.; Nagase T.; Kikuno R.F.;
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3); VARIANT ALA-131;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.